Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
AXGN

Market Cap: $2.27B

AI

AxoGen, Inc.

AXGN

NASDAQ (NASDAQ Capital Market)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin74.56%

EBITDA Margin-5.88%

EBIT Margin-8.59%

Pre-tax Margin-13.36%

Net Profit Margin-13.36%

Earnings Yield-1.49%

Valuation Multiples

Price / Book8.78

Price / Sales9.02

Price / Earnings-62.48

PEG0.30

Forward PEG-1.18

EV / Sales8.73

EV / EBITDA-148.40

EV / Operating Cash Flow235.20

EV / Free Cash Flow867.81

Price / Free Cash Flow897.30

Price / Operating Cash Flow241.29

Cash Flow & Capital

Free Cash Flow / Share$0.05

Operating Cash Flow / Share$0.17

Free Cash Flow Yield0.11%

Capex / Revenue2.70%

Capex / Operating Cash Flow72.90%

Capex / Depreciation0.77

Stock Compensation / Revenue14.99%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio6.60

Quick Ratio5.04

Cash Ratio3.11

Debt / Assets0.07

Debt / Capital0.07

Debt / Equity0.08

Long-Term Debt / Capital0.07

Debt / Market Cap0.80%

Net Debt / EBITDA5.04

Solvency Ratio-0.55

Financial Leverage1.19

Efficiency & Working Capital

Asset Turnover0.82

Fixed Asset Turnover2.61

Inventory Turnover1.35

Receivables Turnover7.36

Payables Turnover2.25

Days Sales Outstanding49.59

Days Inventory Outstanding270.22

Days Payables Outstanding162.19

Operating Cycle319.81

Cash Conversion Cycle157.61

Working Capital Turnover1.53

Returns & Quality

Return on Equity-17.88%

Return on Assets-11.00%

Return on Invested Capital-4.65%

ROCE-4.68%

Return on Tangible Assets-11.28%

Operating Return on Assets-4.32%

Income Quality-0.28

Tax Burden1.00

Interest Burden1.56

Balance Sheet & Intrinsic Metrics

Enterprise Value$2.19B

Invested Capital$273.76M

Working Capital$170M

Tangible Asset Value$248.69M

Net Current Asset Value$151.77M

Graham Net-Net$1.79

Book Value / Share$4.8

Tangible Book Value / Share$4.66

Cash / Share$1.77

Financial Health Scores

Piotroski Score4

Altman Z-Score27.92

Revenue$251.17M

EBIT$-21.57M

Market Cap$2.28B

Working Capital$170M

Retained Earnings$-328.06M

Total Assets$304.86M

Total Liabilities$48.61M